| Literature DB >> 27346350 |
Colm E Nestor1, Antonio Lentini2, Cathrine Hägg Nilsson2, Danuta R Gawel2, Mika Gustafsson3, Lina Mattson2, Hui Wang4, Olof Rundquist2, Richard R Meehan5, Bernward Klocke6, Martin Seifert6, Stefanie M Hauck7, Helmut Laumen8, Huan Zhang2, Mikael Benson9.
Abstract
5-methylcytosine (5mC) is converted to 5-hydroxymethylcytosine (5hmC) by the TET family of enzymes as part of a recently discovered active DNA de-methylation pathway. 5hmC plays important roles in regulation of gene expression and differentiation and has been implicated in T cell malignancies and autoimmunity. Here, we report early and widespread 5mC/5hmC remodeling during human CD4(+) T cell differentiation ex vivo at genes and cell-specific enhancers with known T cell function. We observe similar DNA de-methylation in CD4(+) memory T cells in vivo, indicating that early remodeling events persist long term in differentiated cells. Underscoring their important function, 5hmC loci were highly enriched for genetic variants associated with T cell diseases and T-cell-specific chromosomal interactions. Extensive functional validation of 22 risk variants revealed potentially pathogenic mechanisms in diabetes and multiple sclerosis. Our results support 5hmC-mediated DNA de-methylation as a key component of CD4(+) T cell biology in humans, with important implications for gene regulation and lineage commitment.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27346350 PMCID: PMC5868728 DOI: 10.1016/j.celrep.2016.05.091
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423